Background and purpose During the years prior to the turn of the century, scientific and
medical attention for genetic disorders was mainly focused on understanding rare single …

The US Supreme Court's recent decision in Association for Molecular Pathology v. Myriad
Genetics, Inc. declared, for the first time, that isolated human genes cannot be patented …

Do intellectual property (IP) rights on existing technologies hinder subsequent innovation?
Using newly collected data on the sequencing of the human genome by the public Human …

Over the last two decades changes in technology and policy have altered the landscape of
drug discovery. These changes have led to concerns that the patent system may be creating …

Knowledge-based firms seeking competitive advantage often draw on the public knowledge
stream (ideas embedded in public commons institutions) as the foundation for private …

Over the past thirty years, the world's patent systems have experienced pressure from civil
society like never before. From farmers to patient advocates, new voices are arguing that …

The US patent system is in an accelerating race with human ingenuity and investments in
innovation. In many respects the system has responded with admirable flexibility, but the …

Policy Forum www. sciencemag. org SCIENCE VOL 309 23 SEPTEMBER 2005 2003
genomics researchers in our sample, the denial rate for 2003–04 was 18%(95% confidence …

From the late 1980s, a storm surrounding the wisdom, ethics, and economics of human gene
patents has been brewing. The various winds of concern in this storm touched on the impact …

Evidence and anecdotes: an analysis of human gene patenting controversies | Nature
Biotechnology Skip to main content Thank you for visiting nature.com. You are using a browser …